FDA Acting Commissioner Schwetz Pledges To Maintain Agency Science Base

Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make a priority of funding the agency's science base, he said in a Jan. 22 email to agency staff.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet